Matthew Breyer

Matthew Breyer

Company: Johnson & Johnson

Job title: Distinguished Scientist


Using Animal Models of Chronic Kidney Disease to Inform Drug Discovery & Mechanisms of Action 12:00 pm

Evaluating differential drug responses in animal models of chronic kidney disease Using genetically modified mouse models to enable mechanistic understanding of kidney disease Employing omics platforms to characterize models that are most relevant to specific disease etiologyRead more

day: Track 1 - Day 2 AM

Panel Discussion: Identifying & Validating a Novel Therapy to Complement SGLT2 Inhibitors 9:30 am

Defining the next wave of therapeutics discovery after SGLT2i to improve clinical outcomes Measuring incremental benefit of novel therapeutics in addition to SGLT2 inhibitors Optimizing a smart preclinical screening platform to monitor efficacy in addition to standard of care Considering innovative trial design and untraditional endpoints to demonstrate efficacy and meet regulatory requirementsRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.